Hanley S. Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes. McGill J Med [Internet]. 2020 Aug. 12 [cited 2024 Apr. 26];12(2). Available from: https://mjm.mcgill.ca/article/view/267